Technology driven

Technology driven biopharma player with differentiated portfolio and global presence

Know More

12th largest in India

Ranked one of the fastest growing and 12th largest pharma player in India
(* as per AIOCD-AWACS June 2024)

Know More

Committed to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives

We are one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

icons
12th Largest Pharma Company in India,
In terms of Domestic Sales for MAT June 2024
icons
10,852 Employees
As of September 30, 2023
icons
70+ Countries with presence

Focus Areas

Established presence in key therapeutic areas

Gynaecology
Cardiology
Anti-infective
Vitamins, minerals and nutrients
Diabetes
Anti-Retro Virals
Biologics
mRNA vaccine

Research and Development

We are a research and development driven company with a differentiated product portfolio that includes orals, injectables and biotherapeutics. Our in-house research and development capabilities are the cornerstone of our operations and continued growth.

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more

Our Presence

Emcure Pharmaceuticals is present in over 70+ Countries through its network and distribution channels

India
Canada
Mexico
Peru
Brazil
Chile
UK
Netherlands
Germany
France
Italy
Croatia
Spain
Nigeria
South Africa
Kenya
Dubai
Kazakhstan
Russia/CIS
Myanmar
Vietnam
Philipines
Australia

Newsroom

August 27, 2024

After 40% gains from IPO price, new listing Emcure Pharma may see further upside, says Jefferies

Read more
August 15, 2024

Emcure Pharma Q1 net up 8%

Read more
August 14, 2024

Emcure Q1 Results: Net profit rises 8.2% to Rs 153 crore, revenue up 16%

Read more
August 2, 2024

Emcure Pharma Partners With Moms To Normalise Public Breastfeeding For World Breastfeeding Week

Read more
July 31, 2024

Emcure to buy solar power from Sunsure Energy

Read more
June 12, 2024

Ola Electric, Emcure Pharma among 12 companies to launch IPOs in next 2 months

Read more
Placeholder Image

Life at Emcure

We aim to enhance and sustain the performance of our employees by continuously developing both functional and behavioral competencies across businesses.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.

explore